Is a complete PCSA research report available?

No complete published report is available for Processa Pharmaceuticals, Inc. (PCSA) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Processa Pharmaceuticals, Inc. (PCSA)

NASDAQ: PCSA · USD

$2.60

-0.27 (-9.4%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-26 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first PCSA analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	7.2M
Net income (ttm)	-14.1M
EPS (ttm)	-$7.54
Shares out	2.8M
Volume	129,447
Beta	0.99

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -14.1M
EPS (ttm): -$7.54
Market cap: 7.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All PCSA indicators

Market & fundamental data

Available fields

175

Groups with data

Currency

USD

Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001533743
Company name	Processa Pharmaceuticals, Inc.
Country	United States
Country code	US
Cusip	74275C403
Employees	12
Employees Change	2%
Employees Change Percent	20
Enterprise value	$5.5M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US74275C4033
Last refreshed	2026-07-26
Market cap	$7.2M
Market cap category	Nano-Cap
Price	$2.6
Price currency	USD
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.79
Sic	2834
Symbol	PCSA
Website	https://www.processapharmaceuticals.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-197.28%
FCF yield	-171.26%
P/B ratio	2.74x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-14.1M
Net Income Growth Years	0%
Profit Per Employee	$-1.2M
ROA	-193.9
Roa5y	-105
ROCE	-569.6
ROE	-465
Roe5y	-223.9
ROIC	-295.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-56.78%
Cagr3y	-76.07%
Cagr5y	-76.34%
EPS Growth Quarters	13
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$4.5M
Cash	$1.7M
Current Assets	$1.9M
Current Liabilities	$2M
Debt	$0
Equity	$2.5M
Liabilities	$2M
Long Term Assets	$2.6M
Long Term Liabilities	$0
Net Cash	$1.7M
Net Cash By Market Cap	$23.65
Net Cash Growth	-40.61%
Net Debt Equity	$-0.67
Tangible Book Value	$2.5M
Tangible Book Value Per Share	$0.95
WACC	9.67

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.98
Net Working Capital	$-1.7M
Quick ratio	0.85
Working Capital	$-41,687

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-878.52%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-56.76%
200-day SMA	3.95
3Y total return	-98.63%
50-day SMA	2.33
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.93%
All Time High	125,195.1
All Time High Change	-100%
All Time High Date	2017-10-19
All Time Low	1.67
All Time Low Change	55.69%
All Time Low Date	2026-07-08
ATR	0.25
Beta	0.99
Beta1y	0.7
Beta2y	0.35
Ch YTD	-9.72
High	2.87
High52	14.24
High52 Date	2025-10-08
High52ch	-81.75%
Low	2.52
Low52	1.67
Low52 Date	2026-07-08
Low52ch	55.69%
Ma50ch	11.64%
Premarket Change Percent	-5.92
Premarket Price	$2.7
Premarket Volume	8,027
Price vs 200-day SMA	-34.14%
RSI	58.38
RSI Monthly	26.68
RSI Weekly	43.97
Sharpe ratio	0.29x
Sortino ratio	0.58
Total Return	-878.52%
Tr YTD	-9.72
Tr1m	28.71%
Tr1w	12.55%
Tr3m	-13.04%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-1
Operating Income	$-14.5M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,643,275%
Float Percent	96.11%
Net Borrowing	-5,066
Shares Insiders	3.71%
Shares Institutions	21.42%
Shares Out	2,750,173
Shares Qo Q	16.25%
Shares Yo Y	878.52%
Short Float	3.26%
Short Ratio	1.36
Short Shares	3.13

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-13M
Average Volume	72,008.55x
Bv Per Share	0.95
Ch1m	28.71
Ch1w	12.55
Ch1y	-56.76
Ch3m	-13.04
Ch3y	-98.63
Ch5y	-99.93
Ch6m	-20.25
Change	-9.41%
Change From Open	-5.8
Close	2.87
Days Gap	-3.83
Depreciation Amortization	1,204
Dollar Volume	336,562.2
Earnings Date	2026-08-10
Earnings Time	bmo
EBIT	$-14.5M
EBITDA	$-14.4M
EPS	$-7.54
F Score	1
FCF	$-12.2M
FCF EV Yield	-224.31x
FCF Per Share	$-4.45
Financing CF	12,390,013
Fiscal Year End	December
Founded	2,011
Investing CF	-1,350,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Date	2025-12-17
Last Split Type	Reverse
Last10k Filing Date	2026-03-18
Ma150	2.69
Ma150ch	-3.2%
Ma20	2.18
Ma20ch	19.21%
Net CF	-1,206,029
Next Earnings Date	2026-08-07
Open	2.76
Optionable	No
Position In Range	22.86
Post Close	2.6
Postmarket Change Percent	1.92
Postmarket Price	$2.65
Ppne	3,511
Pre Close	2.87
Price Date	2026-07-24
Ptbv Ratio	2.81
Relative Volume	1.8x
Share Based Comp	725,802
Tr6m	-20.25%
Us State	Florida
Volume	129,447

Processa Pharmaceuticals, Inc. (PCSA)

Coverage state: Market snapshot only — no published research

Generate the first PCSA analysis

Price

Financial snapshot

Fair-value bridge

Latest news · PCSA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PCSA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on PCSA

Frequently asked questions